FDA Announces Changes To ED Drug Labels

Law360, New York (October 19, 2007, 12:00 AM EDT) -- The U.S. Food and Drug Administration said Thursday that it has approved labeling changes for three popular erectile dysfunction drugs to better warn consumers about a possible risk of sudden hearing loss.

Pfizer Inc.'s Viagra, Eli Lilly & Co.'s Cialis, and Levitra, marketed jointly by Schering-Plough Corp. and GlaxoSmithKline Inc., already include warning labels for possible auditory side effects. The new labels will display a more prominent and specific warning about sudden hearing loss, and include new information for patients about what they should do if...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.